Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Clinical Lung Cancer|January 14, 2017
Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung CancerDavid R Gandara, Jonathan W Riess, Karen Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Aurora kinases as anticancer drug targetsOliver Gautschi, Jim Heighway, Philip C Mack, et al.
Vaccines|May 27, 2023
Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short ReviewAnanda M Rodilla, Sooyun Tavolacci, Jazz Cagan, et al.
Radiation Research|November 19, 2004
Enhancement of radiation cytotoxicity by UCN-01 in non-small cell lung carcinoma cellsPhilip C Mack, Angela A Jones, Matthew H Gustafsson, et al.
International Journal of Cancer|July 28, 2011
Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migrationLanfang Bai, Joy C Yang, Joon-ha Ok, et al.
BJU International|June 21, 2008
Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell linesRebekah A Burich, William S Holland, Ruth L Vinall, et al.
Cancer Chemotherapy and Pharmacology|May 2, 2003
Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinomaPhilip C Mack, David R Gandara, Alvin H Lau, et al.
Clinical Lung Cancer|October 28, 2005
Bortezomib-based combinations in the treatment of non-small-cell lung cancerAngela M Davies, Primo N Lara, Philip C Mack, et al.
Clinical Lung Cancer|October 28, 2005
Proteasome inhibition in small-cell lung cancer: preclinical rationale and clinical applicationsPrimo N Lara, Richard J Bold, Philip C Mack, et al.
Cancers|March 13, 2024
ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung CancerAakash Desai, Tadana A Vázquez, Keishla M Arce, et al.
Pageof 13